INDEGENE LIMITED Share Price

INDEGENE LIMITED Share Price

NSE: INDGN
|
Pharmaceuticals
|
S Cap
₹ 600.60
+₹0.45 (0.07%)
1D
Last updated 03 Sep, 2026, 10:47 IST

INDEGENE LIMITED Share Price Today

As of 3 Sep 2026, INDEGENE LIMITED share price is ₹600.60. The stock opened at ₹603.55, compared to its previous close of ₹600.15. During today's trading session, INDEGENE LIMITED share price moved in the range of ₹597.05 to ₹603.65, with an average price of ₹600.35 for the day. Looking at its last 52-week, the stock has touched a low of ₹414.00 and a high of ₹615.50. On the performance front, INDEGENE LIMITED share price has increased by 25.04% over the last six months and is up 9.92% on a year-on-year basis.

₹597.05
0.07% up today
₹603.65
1D LOW
1D HIGH

INDEGENE LIMITED Returns Calculator

Circuit
L
H
₹480.15
₹720.15
52-week
L
H
₹414.00
₹615.50

About INDEGENE LIMITED

INDEGENE LIMITED Share Price
ISIN
INE065X01017
Sector Market Cap
₹ 14,455.5 Cr

Indegene Limited is an India-based tech-native, life sciences commercialization company. The Company provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. Its segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Brand Activation, and Others. The Enterprise Commercial Solutions business unit caters to the digital marketing operations of life sciences companies. The Enterprise Medical Solutions consolidates large-scale regulatory and medical operations for life sciences companies. The Brand Activation segment offers promotion of biopharmaceutical products and medical devices to HCPs for life sciences companies across channels. It provides customized marketing campaigns through a comprehensive portfolio of proprietary program offerings. Others mainly consist of consultancy and clinical business.

INDEGENE LIMITED Financial Highlights

  • Revenue: INDEGENE LIMITED reported revenue of ₹3,582.50 crore in FY26 vs ₹2,946.50 crore in FY25. It showed an increase of 21.58% on a yearly basis.
  • Operating Profit: INDEGENE LIMITED reported an operating profit of ₹525.00 crore in FY26 vs ₹539.30 crore in FY25. It showed a decrease of 2.65% on a year-on-year basis.
  • Net Profit: INDEGENE LIMITED reported a net profit of ₹401.10 crore in FY26 vs ₹406.70 crore in FY25. It showed a decrease of 1.38% on a yearly basis.

INDEGENE LIMITED Quarterly Result Highlights

  • INDEGENE LIMITED reported revenue of ₹1,092.10 crore in Jun 2026, compared with ₹1,014.20 crore in Mar 2026, representing an increase of 7.68% on a quarter-on-quarter (QoQ) basis.
  • INDEGENE LIMITED reported an operating profit of ₹152.70 crore in Jun 2026, compared with ₹105.10 crore in Mar 2026, representing an increase of 45.29% on a quarter-on-quarter (QoQ) basis.
  • INDEGENE LIMITED reported a profit of ₹116.20 crore in Jun 2026, compared with ₹79.70 crore in Mar 2026, reflecting an increase of 45.80% on a QoQ basis.
  • The earnings per share (EPS) of INDEGENE LIMITED stood at ₹16.72 during Jun 2026.
Know more
Promoters
0.00%
FII
9.91%
Other DII
3.46%
Retail and other
81.34%
Mutual funds
5.28%
Foreign institutions - FII
FII shareholding by period
Sep 202511.30%
Dec 202511.48%
Mar 202610.27%
Jun 20269.91%
Mkt Cap Cr
14,455.50
P/E
36.06
P/B
4.61
ROE
12.78%
D/E
0.03
ROCE
15.61%
Div. Yield
0.37%
EPS(TTM)
8.83
Turnover
0.53
EV/EBITDA
20.60
Net Margin
17.36%
Op. Margin
26.74%
ROA
8.68%
Quick Ratio
4.66
Curr. Ratio
5.06
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Indegene outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Indegene appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
Indegene revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Apollo Hospitals1,25,998.0057.6913.2220.48%0.3217.27%692.920.23%0.66103.81
MANIPAL HEALTH ENTERPRI L93,280.00102.925.6810.59%0.469.51%0.000.00%0.000.00
Max Healthcare96,743.7066.409.0013.42%0.0912.97%91.840.20%0.277.37
Fortis Healthcare68,991.9064.456.9710.53%0.2312.56%122.240.11%0.153.05
Aster DM Healthcare66,430.20183.2014.508.48%0.3110.10%53.530.23%0.435.20
Narayana Hrudayalaya39,297.6048.128.6617.76%0.7611.42%127.100.23%0.7624.77
Global Health39,162.5070.379.8114.05%0.0615.26%149.240.03%0.7318.46
Dr. Lal Path Labs32,118.7058.7912.8020.13%0.0825.56%147.341.07%0.9130.45
KRISHNA INST OF MED SCI L31,878.50162.728.4410.74%0.637.99%93.540.00%0.426.52
Poly Medicure18,086.4057.805.8210.37%0.0812.71%301.170.20%0.4833.15

INDEGENE LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3,510.50₹2,839.30₹2,589.60₹2,306.10
Other Income₹72.00₹107.20₹76.30₹58.00
Total Revenue₹3,582.50₹2,946.50₹2,665.90₹2,364.10
Total Expenses₹3,037.20₹2,407.20₹2,209.70₹2,001.10
Profit Before Tax₹525.00₹539.30₹458.60₹363.00
Tax₹123.90₹132.60₹121.90₹96.90
Profit After Tax₹401.10₹406.70₹336.70₹266.10
EPS - Basic₹16.72₹17.15₹15.19₹12.03
EPS - Diluted₹16.62₹17.02₹15.07₹11.97

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹525.00₹539.30₹458.60₹363.00
Income before WC changes₹652.20₹577.80₹536.80₹454.40
Change in Assets-₹19.60-₹47.70₹1.10-₹174.60
Change in Liabilities₹165.80₹71.80₹94.70-₹41.40
Change in WC₹146.20₹24.10₹95.80-₹216.00
Cash flow from Operations₹650.80₹441.90₹507.70₹130.20
Cash flow from Investing-₹512.40-₹682.70-₹327.20-₹893.30
Cash flow from Financing-₹82.60₹287.50-₹66.20₹333.10
Total Cash Flow₹55.80₹46.70₹114.30-₹430.00
Cash (Start of the year)₹241.00₹188.60₹73.60₹506.30
Cash (End of the year)₹300.80₹241.00₹188.60₹73.60

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,001.90₹795.90₹754.80₹755.20
Current Assets₹2,618.40₹2,530.00₹1,790.80₹1,448.70
Total Assets₹4,620.30₹3,325.90₹2,545.60₹2,203.90
Current Liabilities₹1,086.20₹564.50₹610.90₹489.10
Net Current Asset₹1,532.20₹1,965.50₹1,179.90₹959.60
Non-Current Liabilities₹395.40₹145.80₹505.60₹651.00
Equity Capital₹3,138.70₹2,615.60₹1,429.10₹1,063.80
Total Equity & Liabilities₹4,620.30₹3,325.90₹2,545.60₹2,203.90

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,220.60₹1,093.60₹1,045.60₹1,005.70
Other Income₹78.30₹90.40₹50.30₹36.80
Total Revenue₹1,298.90₹1,184.00₹1,095.90₹1,042.50
Total Expenses₹1,017.50₹945.50₹915.30₹865.90
Profit Before Tax₹281.40₹238.50₹180.60₹176.60
Tax₹69.50₹57.20₹42.70₹46.40
Profit After Tax₹211.90₹181.30₹137.90₹130.20
EPS - Basic₹8.83₹7.64₹6.22₹5.89
EPS - Diluted₹8.78₹7.59₹6.17₹5.86

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹281.40₹238.50₹180.60₹176.60
Income before WC changes₹265.60₹198.20₹183.10₹209.40
Change in Assets₹122.20₹9.30-₹3.00-₹107.00
Change in Liabilities₹5.70-₹7.90₹45.40₹21.30
Change in WC₹127.90₹1.40₹42.40-₹85.70
Cash flow from Operations₹345.60₹129.00₹176.20₹81.90
Cash flow from Investing-₹272.10-₹824.70-₹187.70-₹47.90
Cash flow from Financing-₹62.60₹717.30-₹15.80-₹16.90
Total Cash Flow₹10.90₹21.60-₹27.30₹17.10
Cash (Start of the year)₹35.20₹13.20₹41.80₹27.80
Cash (End of the year)₹48.50₹35.20₹13.20₹41.80

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,207.00₹931.70₹469.30₹334.80
Current Assets₹1,274.90₹1,218.00₹751.00₹702.90
Total Assets₹2,481.90₹2,149.70₹1,220.30₹1,037.70
Current Liabilities₹273.80₹189.50₹198.10₹169.40
Net Current Asset₹1,001.10₹1,028.50₹552.90₹533.50
Non-Current Liabilities₹127.60₹72.00₹68.40₹73.00
Equity Capital₹2,080.50₹1,888.20₹953.80₹795.30
Total Equity & Liabilities₹2,481.90₹2,149.70₹1,220.30₹1,037.70
* All values are in INR Crore
Qty
Bid
74
600.25
22
600.2
38
600.15
93
600.1
128
600.05
Ask
Qty
600.65
50
600.8
21
600.85
71
600.9
45
600.95
73
Bid Total: 355
Ask Total: 260
Buy orders: 58%
Sell orders: 42%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
68.9
Neutral
ATR (14)
16.51
Neutral
STOCH(9,6)
73.65
Neutral
STOCH RSI (14)
51.77
Neutral
ADX(9)
38.74
Bearish
UO(9)
57.42
Neutral
ROC(12)
6.84
Bullish
WillR(14)
-24.19
Neutral
Period
Simple value
Exponential vaue
5D
592.7
594.37
10D
579.79
584.3
20D
571.25
570.41
50D
535.72
546.68
100D
524.31
529.68
Volume trend — traded volume by day
3 Sep2L
2 Sep6L
1 Sep9L
31 Aug39L
28 Aug18L
27 Aug4L
Average13L
Compare against other stocks
INDEGENE LIMITED Share Price
INDEGENE LIMITED
Pharmaceuticals
Add Stock
Add Another

INDEGENE LIMITED Share Price FAQs